Citation Impact
Citing Papers
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
2010
Colorectal cancer statistics, 2020
2020 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Colorectal cancer statistics, 2023
2023 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
2015
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
1996
Combinatorial drug therapy for cancer in the post-genomic era
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
TGF-β signalling-related markers in cancer patients with bone metastasis
2008
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
Use of bisphosphonates in cancer patients
1996
Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CAin a single reaction by multiplex assay kit
2013
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Colorectal cancer
2013 Standout
Treatment of Non-Hodgkin's Lymphoma
1993
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Systematic review of bisphosphonates for hypercalcaemia of malignancy
2004
The Epidemiology of Distal Radius Fractures
2012 Standout
Hypercalcemia Associated with Cancer
2005
Biology of Natural Killer Cells
1989 Standout
Telomeres, telomerase and senescence
1990 StandoutNobel
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Attenuated T Cell Responses to a High-Potency Ligand In Vivo
2010 StandoutNobel
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
2013
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice
1992 StandoutNatureNobel
Phosphine-Catalyzed α-P-Addition on Activated Alkynes: A New Route to P−C−P Backbones
2006
Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
2009
Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex
2001
Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer
2011 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Bisphosphonates: mechanisms of action.
1996
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Large deletions result from breakage and healing of P. falciparum chromosomes
1988
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Intravenous Ibandronate Acutely Reduces Bone Hyperresorption in Chronic Critical Illness
2011
Magnesium in Man: Implications for Health and Disease
2014 Standout
Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus.
1992
NK CELL RECEPTORS
1998 Standout
Strength of TCR–Peptide/MHC Interactions and In Vivo T Cell Responses
2011 StandoutNobel
Phosphine Organocatalysis
2018 Standout
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
2019
Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes
1993 StandoutNobel
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies
2011
Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region.
1987
Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.
1989
Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
2009
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Evolving Treatment of Advanced Colon Cancer
2009
Renal Control of Calcium, Phosphate, and Magnesium Homeostasis
2014 Standout
Skeletal complications of malignancy
1997 Standout
Multiple Myeloma
2011 Standout
The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses.
1988
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Structure and function of telomeres
1991 StandoutNatureNobel
Bisphosphonates: Mechanisms of Action
1998
Second-Line Systemic Therapy for Metastatic Urothelial Carcinoma of the Bladder
2013
A systematic review of the role of bisphosphonates in metastatic disease
2004
Works of E.U. Steinhauer being referenced
Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate
2003
Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy
1999
Sequential versus alternating chemotherapy for high grade non‐hodgkin's lymphomas: A randomized multicentre trial
1991
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
1996
Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.
1986
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
2008